Nortis, a Seattle-based startup developing ‘organ-on-a-chip’ tech, raises cash

30
Oct
  • Prime healthcare: How Amazon’s $3.9B One Medical deal could boost its subscription program
  • Dr. Anthony Fauci stops in Seattle for Fred Hutch Q&A, throws first pitch at Mariners game
  • Fred Hutch spinout lands $10M for precision test to guide cancer treatment, develop drugs
  • Publicly traded biotech company Absci lays off employees, citing ‘macro-economic conditions’
  • Seattle startup HDT Bio lands $1.8M U.S. Army grant to develop nasal spray against viruses

    • Nortis, a Seattle-area startup based in 2011 that markets “organ-on-a-chip” know-how, has raised $6 million, in keeping with an SEC submitting.

    The corporate’s microfluidic chips foster the expansion of human cells in ways in which resemble organs, and have been used to create kidney, liver, blood vessel, coronary heart, gut, and tumor fashions for researchers.

    Nortis has beforehand acquired backing from the Invoice & Melinda Gates Basis and collaborated on a venture to ship a kidney chip into area. Its chips are utilized in analysis research. The corporate spun out of VisionGate and is led by Thomas Neumann, a former exec at VisionGate.

    We’ve reached out to the corporate for extra particulars in regards to the new funding and can replace if we hear again.

    See also  Startup developing a hand-held ultrasound tool for the bedside lands $57M
    Megusta

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    Block "video-noi-bat" not found